SMI Adviser
Long-Acting Injectable
Center of Excellence

The Long-Acting Injectable (LAI) Center of Excellence (COE) provides FREE resources, education, consultation, tools and more on the use of LAIs. Let SMI Adviser help you increase and improve the use of LAIs in individuals with schizophrenia and bipolar disorder. The LAI COE is led by SMI Adviser Physician Expert, Alexander Young, MD, MSHS, and SMI Nursing Expert, Donna Rolin, PhD, APRN, and supported by members of the LAI Workgroup: Oliver Freudenreich, MD, Sarah MacLaurin, PMHNP, Jon Medina, PMHNP, Robert Cotes, MD, and Leon Ravin, MD.

For individual and family resources on using long-acting injectables, visit the individual and family Knowledge Base.

Learn More About Long-Acting Injectables

Long-acting injectable medications (LAIs) can streamline the pharmacotherapy for many patients with schizophrenia or bipolar disorder. Not only do they facilitate medication adherence, they also provide the most consistent serum levels of antipsychotic (and mood stabilizing) medication. They keep medication routines more manageable than oral medications allow. LAIs can provide convenience for patients who do not want to take daily medication, and can help patients who have difficulty maintaining a consistent daily medication regime.

A clinician discusses a treatment plan provided on SMI Adviser.
A pharmacist provides a patient with a Clozapine prescription.

Resources on Long-Acting Injectables

Browse resources and find answers from the SMI Adviser Knowledge Base


Request a Consultation

Our clinical experts can answer questions about SMI from all mental health clinicians. Ask us about psychopharmacology, therapies, recovery supports, patient and family engagement, education, and much more.

Submit Now

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Saved Posts